Repeated intravenous administrations of teneurin-C terminal associated peptide (TCAP)-1 attenuates reinstatement of cocaine seeking by corticotropin-releasing factor (CRF) in rats

Behav Brain Res. 2014 Aug 1:269:1-5. doi: 10.1016/j.bbr.2014.04.013. Epub 2014 Apr 21.

Abstract

The teneurin c-terminal associated peptides (TCAP) have been implicated in the regulation of the stress response, possibly via a corticotropin-releasing factor (CRF)-related mechanism. We have previously shown that repeated intracerebroventricular (ICV) injections of TCAP-1 attenuate the reinstatement of cocaine seeking by CRF in rats. Here, we determined whether intravenous (IV) administrations of TCAP-1 would likewise attenuate CRF-induced reinstatement, and whether this effect would vary depending on the rat's history of cocaine self administration. Rats were trained to self-administer cocaine for 10 days, during once daily sessions that were either 3h ("short access"; ShA) or 6h ("long access"; LgA). Rats were then given five daily injections of TCAP-1 (0, 300, or 3,000 pmol, IV) in their home cage. Subsequently, they were returned to the self-administration chambers where extinction of cocaine seeking and testing for CRF-induced reinstatement of cocaine seeking was carried out. Repeated IV administrations of TCAP-1 were efficacious in attenuating CRF-induced reinstatement of cocaine seeking, but at different doses in ShA and LgA rats. Taken together, the findings extend previous work showing a consistent effect of repeated ICV TCAP-1 on CRF-induced reinstatement of cocaine seeking, and point to a potential therapeutic benefit of TCAP-1 in attenuating cocaine seeking behaviors.

Keywords: CRF; Cocaine; Intravenous; Reinstatement; TCAP; Teneurin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous
  • Animals
  • Central Nervous System Agents / therapeutic use*
  • Cocaine / administration & dosage
  • Cocaine-Related Disorders / drug therapy*
  • Cocaine-Related Disorders / physiopathology
  • Corticotropin-Releasing Hormone / pharmacology
  • Dopamine Uptake Inhibitors / administration & dosage
  • Dose-Response Relationship, Drug
  • Drug-Seeking Behavior / drug effects*
  • Extinction, Psychological / drug effects
  • Male
  • Peptides / administration & dosage*
  • Peptides / therapeutic use
  • Rats, Long-Evans
  • Self Administration

Substances

  • Central Nervous System Agents
  • Dopamine Uptake Inhibitors
  • Peptides
  • teneurin-C terminal associated peptide
  • Corticotropin-Releasing Hormone
  • Cocaine